4053-35-4Relevant articles and documents
PRMT5 INHIBITOR COMPOUNDS
-
Page/Page column 38; 40, (2020/10/20)
A series of PRMT5 inhibitor compounds are described. The compounds are useful as PRMT5 inhibitor compounds and in the treatment of PRMT5 mediated diseases, disorders, and symptoms thereof.
Enantioselective Intermolecular [2 + 2] Photocycloaddition Reactions of 2(1H)-Quinolones Induced by Visible Light Irradiation
Tr?ster, Andreas,Alonso, Rafael,Bauer, Andreas,Bach, Thorsten
, p. 7808 - 7811 (2016/07/07)
In the presence of a chiral thioxanthone catalyst (10 mol %) the title compounds underwent a clean intermolecular [2 + 2] photocycloaddition with electron-deficient olefins at λ = 419 nm. The reactions not only proceeded with excellent regio- and diastereoselectivity but also delivered the respective cyclobutane products with significant enantiomeric excess (up to 95% ee). Key to the success of the reactions is a two-point hydrogen bonding between quinolone and catalyst enabling efficient energy transfer and high enantioface differentiation. Preliminary work indicated that solar irradiation can be used for this process and that the substrate scope can be further expanded to isoquinolones.
2-aminoquinoline-based compounds for potent and selective neuronal nitric oxide synthase inhibition
-
Page/Page column 7; 8; 32, (2016/01/09)
Various 2-aminoquinoline compounds as can be used, in vivo or in vitro, for selective inhibition of neuronal nitric oxide synthase.